| James F. Reppert, M.d. | |
|
1335 Phay Ave Ste A Canon City CO 81212-2349 | |
| (719) 275-4151 | |
| (719) 275-3743 |
| Full Name | James F. Reppert, M.d. |
|---|---|
| Speciality | Internal Medicine |
| Location | 1335 Phay Ave Ste A, Canon City, Colorado |
| Authorized Official Name and Position | James Fred Reppert (SOLE PROPRIETORSHIP) |
| Authorized Official Contact | 7192754151 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| James F. Reppert, M.d. 1335 Phay Ave Ste A Canon City CO 81212-2349 Ph: (719) 275-4151 | James F. Reppert, M.d. 1335 Phay Ave Ste A Canon City CO 81212-2349 Ph: (719) 275-4151 |
| NPI Number | 1093739757 |
|---|---|
| Provider Enumeration Date | 07/26/2006 |
| Last Update Date | 03/29/2021 |
| Medicare PECOS PAC ID | 8921997362 |
|---|---|
| Medicare Enrollment ID | O20040312001029 |
News Archive
Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.
Covidien plc today reported results for the second quarter of fiscal 2013 (January - March 2013). Second-quarter net sales of $3.10 billion increased 5% from the $2.95 billion reported in the second quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.
Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093739757 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 22797 (Colorado) | Primary |
| Provider Name | James Reppert |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1285632893 PECOS PAC ID: 9638068083 Enrollment ID: I20050330000335 |
News Archive
Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.
Covidien plc today reported results for the second quarter of fiscal 2013 (January - March 2013). Second-quarter net sales of $3.10 billion increased 5% from the $2.95 billion reported in the second quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.
Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 7 days ago
| Provider Name | Jessie M Niedens |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356990360 PECOS PAC ID: 5890026363 Enrollment ID: I20191015000236 |
News Archive
Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.
Covidien plc today reported results for the second quarter of fiscal 2013 (January - March 2013). Second-quarter net sales of $3.10 billion increased 5% from the $2.95 billion reported in the second quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.
Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 7 days ago
News Archive
Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.
Covidien plc today reported results for the second quarter of fiscal 2013 (January - March 2013). Second-quarter net sales of $3.10 billion increased 5% from the $2.95 billion reported in the second quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.
Having a family history of prostate cancer among first-degree relatives may increase a woman's risk of developing breast cancer. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 7 days ago
Desert River Family Medicine, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 712 Macon Ave, Canon City, CO 81212 Phone: 719-285-8890 | |
Ncaldwell Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1338 Phay Ave, Canon City, CO 81212 Phone: 702-453-3799 Fax: 702-453-5741 | |
Rocky Mountain Clinics Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1121 Main St, Canon City, CO 81212 Phone: 209-309-1885 | |
Button Family Practice Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 715 South 9th Street, Canon City, CO 81212 Phone: 719-269-8820 Fax: 719-204-0230 | |
Marc A. Sindler, Md Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 215 N 5th St, Canon City, CO 81212 Phone: 719-275-4137 | |
Solvista Health Corp. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3225 Independence Rd, Canon City, CO 81212 Phone: 719-275-2351 |